COVID-19 vaccination in Mexico

Last updated

COVID-19 vaccination in Mexico
DateDecember 24, 2020 (2020-12-24) – present
Location Mexico
Cause COVID-19 pandemic in Mexico

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Contents

Background

COVID-19 vaccine vials being made ready for delivery at a vaccination centre in Mexico Vacunacion contra COVID 01.jpg
COVID-19 vaccine vials being made ready for delivery at a vaccination centre in Mexico

By September 25, 2021, Mexico had administered a total of 97,523,789 doses (74.87 vaccine doses per 100 people), with 54,275,054 residents having received at least one dose and 43,248,659 residents fully vaccinated. [1] Mexico has purchased 310.8 million vaccines doses which covers 141.2% of its population. [2]

Wealthy Mexicans were reported to travel to the neighbouring United States for receiving their vaccinations. [3] In March, the White House announced that four million of doses of COVID-19 vaccines manufactured in the United States will be sent to Mexico. [4] [5]

In a survey conducted in March 2021, 52% of the Mexicans said that they were willing to get vaccinated against COVID-19, 20% said they were not sure and 28% said they would not get vaccinated. [6]

On 20 April 2021, President López Obrador televised himself receiving the AstraZeneca vaccine. [7] [8]

National vaccination plan

The National vaccination plan against COVID-19 has been planned as below in Mexico: [9]

Vaccines on order

NOT UPDATED SINCE APRIL 2021 - Mexico has contracted 79.4 million doses of the AstraZeneca/Oxford vaccine, 35 million doses of the CureVac vaccine, 22 million doses of the Johnson & Johnson vaccine, 39 million doses of the Moderna vaccine, 10 million doses of the Novavax vaccine, 34.4 million doses of the BioNTech/Pfizer vaccine, 24 million doses of the Sputnik V vaccine, 35 million doses of Convidecia, 12 million doses of the Sinopharm BIBP vaccine and 20 million doses of CoronaVac. [2] 3,305,000 doses of the AstraZeneca/Oxford vaccine have been delivered through the COVAX mechanism, [12] a global initiative that aims at equitable distribution for Covid-19 vaccines. Moreover, the United States have sent 2.5 million doses of the AstraZeneca/Oxford vaccine to Mexico. [13]

The following vaccines are authorized by the Mexican government for use against COVID-19 (approval date in parentheses): [9]

VaccineApproval [14] Deployment
Pfizer–BioNTech Green check.svg December 11, 2020Green check.svg December 24, 2020
Oxford–AstraZeneca Green check.svg January 4, 2021Green check.svg Yes
Convidecia Green check.svg February 8, 2021Green check.svg Yes
Sputnik V Green check.svg February 9, 2021Green check.svg Yes
CoronaVac Green check.svg February 9, 2021Green check.svg Yes
Covaxin Green check.svg April 6, 2021Dark Red x.svg Not yet
Janssen Green check.svg May 27, 2021Green check.svg June 17, 2021 [15]
Moderna Green check.svg August 17, 2021Green check.svg Yes
Sinopharm BIBP Green check.svg August 27, 2021Dark Red x.svg Not yet
Abdala Green check.svg December 28, 2021Dark Red x.svg Not yet

Vaccines in trial stage

VaccineType (technology)Phase IPhase IIPhase III
Novavax SubunitGreen check.svg CompletedGreen check.svg CompletedGreen check.svg Completed
GRAd-COV2 Viral vectorGreen check.svg CompletedGreen check.svg CompletedIn progress
Patria Viral vectorGreen check.svg CompletedIn progressDark Red x.svg Not yet

Manufacture and distribution of vaccines in Mexico

The Secretary of Foreign Affairs, Marcelo Ebrard, released the details of the agreement between the government of Mexico, Argentina, the pharmaceutical company AstraZeneca and the Carlos Slim Foundation to produce and distribute the vaccine developed by the University of Oxford. [16]

The strategy to distribute the vaccine in Latin America, the product manufactured in the Argentine mAbxience laboratory, will be transferred to the Mexican facilities of the Liomont laboratory, which will be in charge of completing the stabilization, manufacturing and packaging process of the vaccine. The COVID-19 vaccine from the pharmaceutical company CanSino Biologics will be packaged in Querétaro, after the company requested from COFEPRIS, authorization for its emergency use of its vaccine. [17]

See also

Related Research Articles

COVID-19 pandemic in Panama Ongoing COVID-19 viral pandemic in Panama

The COVID-19 pandemic in Panama is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Panama on 9 March 2020. One of the dead was a 64-year-old male, who also suffered from complications of diabetes and pneumonia. Of those infected, 83 were admitted to hospital. The infected individuals belong to the 29-59 age group and had each recently travelled abroad. A 13-year-old girl died of COVID-19 on 23 March.

COVID-19 pandemic in Uruguay Ongoing COVID-19 viral pandemic in Uruguay

The COVID-19 pandemic in Uruguay is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first cases in Uruguay were reported on 13 March 2020 by the Ministry of Public Health. The early cases were imported from Italy and Spain, with some local transmissions.

COVAX Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Peru

The COVID-19 vaccination program in Peru is the national vaccination strategy to protect the population against SARS-CoV-2 employing vaccines developed for the COVID-19 pandemic in Peru. Vaccination began on 9 February 2021, after three days of arrival of first vaccines. On a nation message, the head of state Francisco Sagasti confirmed the purchase of 38 millions of vaccines, being one million of vaccines for health personnel.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered.

COVID-19 vaccination in Ghana

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

Vaccination in Mexico includes the use of vaccines in advancing public health. Mexico has a multi-year program for immunisation of children. The immunisation of children is fully covered by the government of Mexico. Mexico has an adverse events committee to monitor the adverse effects of vaccination as well as a standing technical advisory group on immunization.

The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. During the first week, 39,599 doses were applied to health professionals.

COVID-19 vaccination in Bangladesh Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Brazil

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Spain Immunization plan against COVID-19 in Spain

The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. "COVID Vaccinations in the Americas > Country/Territory Details > Mexico". Pan American Health Organization (PAHO). Retrieved September 25, 2021.
  2. 1 2 "Timeline: Tracking Latin America's Road to Vaccination". AS/COA. Retrieved June 3, 2021.
  3. LINTHICUM, KATE; HENNESSY-FISKE, MOLLY (March 31, 2021). "With Mexico's vaccination program lagging, wealthy Mexicans are flocking to the U.S." Los Angeles Times. Retrieved April 2, 2021.
  4. "US to send 4m vaccine doses to Canada and Mexico". BBC News. March 18, 2021. Retrieved April 2, 2021.
  5. Kitroeff, Natalie; Abi-Habib, Maria; Kanno-Youngs, Zolan; Tankersley, Jim (March 18, 2021). "U.S. to Send Millions of Vaccine Doses to Mexico and Canada". The New York Times. Retrieved April 2, 2021.
  6. "Mexico ramps up vaccinations as COVID deaths top 200,000". www.aljazeera.com. Retrieved April 2, 2021.
  7. "Lopez Obrador gets COVID jab: 'It protects us all'". www.aljazeera.com. April 20, 2021. Retrieved April 20, 2021.
  8. Jeong, Sophie; Fox, Kara; Pearce, Nicholas (April 20, 2021). "Mexican president will livestream getting vaccinated to reassure the country of its safety". CNN. Retrieved April 20, 2021.
  9. 1 2 "Mexico: The Latest on COVID-19 and Vaccination Measures". The National Law Review. Retrieved April 2, 2021.
  10. "Anuncia gobierno de México que comenzará a vacunar a todos los jóvenes de 15 años en adelante". aristeguinoticias.com (in Spanish).
  11. "Gobierno publica guía de vacunación COVID para menores; contempla 44 padecimientos". www.animalpolitico.com (in Spanish). September 29, 2021.
  12. "Arrival of COVID-19 vaccines to the Americas through COVAX - PAHO/WHO | Pan American Health Organization". www.paho.org. Retrieved June 3, 2021.
  13. Kitroeff, Natalie; Abi-Habib, Maria; Kanno-Youngs, Zolan; Tankersley, Jim (March 18, 2021). "U.S. to Send Millions of Vaccine Doses to Mexico and Canada". The New York Times. ISSN   0362-4331 . Retrieved June 3, 2021.
  14. "COFEPRIS emite autorización para uso de emergencia a vacuna contra covid-19 a las siguientes vacunas". www.gob.mx (in Spanish).
  15. "Inicia hoy vacunación en Baja California para todos los mayores de 18 años". Gobierno de México (in Spanish). June 17, 2021.
  16. de 2021, 21 de Enero. "Así es el laboratorio mexicano que envasará la vacuna Oxford - AstraZeneca para su distribución en toda América Latina". infobae (in Spanish). Retrieved July 27, 2021.
  17. "Envasarán vacuna contra COVID-19 en Querétaro". AM Querétaro (in Spanish). February 6, 2021. Retrieved July 27, 2021.